Dr. Cutler led the team of doctors and biochemist in the development of stabilized allicin found in Allimed.
Dr. Ronald Cutler, an infectious disease specialist and professor at the University of London.
Dr Ronald R Cutler testing AlliSURE stability in the laboratory
Previously established methods like HPLC are outdated and difficult to interpret as each testing laboratory uses different methodology and different standards and is only able to measure allicin release in a test sample. This bears no relation whatsoever to what actually happens in the human body. Any production system that relies on the activity of an acid sensitive enzyme is likely to fail significantly when actually given to human subjects.
Our method is a direct measure of microbiological activity and each test sample of allicin liquid, powder or cream is assayed against a control strain of MRSA (Methicillin Resistant Staphylococcus Aureus). We use approved methods to ascertain the "zone of inhibition " (British Society of Antimicrobial Chemotherapy) foreach batch of allicin liquid, powder or cream. Zone size is directly related to allicin concentration and provided the ring of confidence measures over 12mm then the test extract is deemed capable of destroying MRSA. This methodology will gain full validation whenit is published in full in the medical literature later in 2004."We have developed a new method for testing the stability of standardisedallicin extracts based on microbiological activity" This measurement is a genuine reflection of the ability of the test substance to kill pathogens and this methodology can also clearly demonstrate activity in the human body."